ZNTL
ZNTL
NASDAQ · Biotechnology

Zentalis Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$2.39
+0.18 (+8.14%)
As of Feb 8, 2:09 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 6 40%
Sell 0 0%
Price Target
Analyst Price Target +1,033.5% upside
Low Target $17.95
Average Target $27.09
High Target $27.14
Current Price $2.39
Current
$2.39
Target
$27.09
$17.95 $27.09 avg $27.14
Scenario Analysis
Bear Case
$17.95
651.0%
Low target
Base Case
$27.09
+1,033.5%
Avg target
Bull Case
$27.14
+1,035.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$21.89
-89.1% from high
52-Week Low
$17.84
+-86.6% from low
Target vs 52W High
$27.09
+23.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%